Blood
7
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Phylogenetic Characteristics of Different Candida Species and Their Impact on the Clinical Picture of Patients With Invasive Candidiasis. What Has Changed During the COVID Pandemic?
Combination iSTAT/Alinity and IR Oculography for Head CT Necessity and Recovery Prediction After mTBI
A Novel Cooling Device for Pain Management During Fingerstick Blood Draw
The Effect of Dry Heat and Dry Cold Application on Blood Sampling in Children
Transcriptome Sequencing Analysis of Whole Blood From Patients With Trigeminal Neuralgia
Studying Blood Toxicity in Workers Exposed to Formaldehyde
Examination of the Time Advantage Between POCT and Conventional Central Laboratory Analysis